Status report
Get it in writing
The official USPTO status record for NOVAFLOW, serial 97759861, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
NOVAFLOWSerial 97759861 · Principal Register
Pending · Under Examination
Owner: Astrex Medical Products, LLC
Class 010 -
Filed Jan 18, 2023
The record shows that the mark “NOVAFLOW” is currently pending on the Principal Register, owned by Astrex Medical Products, LLC, a Delaware limited liability company. The application, filed January 18 2023, covers fluid‑delivery health‑care products, specifically infusion pumps. Because the mark is still pending, it does not yet grant nationwide protection, but it does signal that the USPTO has found the mark registrable and has granted multiple extensions for the applicant to file a Statement of Use. The latest event is the approval of a fifth extension on July 21 2026, extending the deadline for the Statement of Use. No opposition, cancellation, or enforcement activity appears in the supplied history. A similar name used for infusion pumps or related fluid‑delivery devices would raise the closest concern, while use in unrelated fields would be farther from the scope shown. For anyone considering a comparable name, the pending status and the specific goods listed suggest a meaningful risk of conflict if the name is used for similar medical equipment.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.